--- title: Evaluating the Feasibility of a Dietary Weight Loss Program to Overcome Obesity and Its Comorbidity Among Arab Populations nct_id: NCT06415695 overall_status: COMPLETED phase: NA sponsor: Asma Yahya study_type: INTERVENTIONAL primary_condition: Overweight and Obesity countries: Saudi Arabia canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06415695.md" clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06415695" ct_last_update_post_date: 2024-12-06 last_seen_at: "2026-05-12T06:26:47.985Z" source: ClinicalTrials.gov (mirrored, no enrichment) --- # Evaluating the Feasibility of a Dietary Weight Loss Program to Overcome Obesity and Its Comorbidity Among Arab Populations **Official Title:** Evaluating the Feasibility of a Dietary Weight Loss Program to Overcome Obesity and Its Comorbidity Among Arab Populations: Pilot Study **NCT ID:** [NCT06415695](https://clinicaltrials.gov/study/NCT06415695) ## Key Facts - **Status:** COMPLETED - **Phase:** NA - **Study Type:** INTERVENTIONAL - **Target Enrollment:** 20 - **Lead Sponsor:** Asma Yahya - **Collaborators:** King Abdullah Medical City - **Conditions:** Overweight and Obesity - **Start Date:** 2024-06-23 - **Completion Date:** 2024-10-07 - **CT.gov Last Update:** 2024-12-06 ## Brief Summary This study aims to develop and test a culturally tailored online weight loss program for the Saudi population. Building upon the success of a previous program in the United States, the research team will adapt educational materials and conduct a pilot study to assess the feasibility and initial outcomes of the program among Arab participants. The study seeks to answer questions about the program's acceptability, effectiveness, and scalability, with the ultimate goal of combating obesity and its related health issues in Saudi Arabia. ## Detailed Description This research project aims to help Saudi individuals lose weight in a way that suits their culture. Obesity is a significant problem and can lead to serious health issues like diabetes and heart problems. Even though Saudi Arabia has attempted to help individuals lose weight before, previous efforts haven't been successful enough. Therefore, the investigators aim to develop a new weight loss program that is better suited to Saudi individuals. First, educational materials will be created in Arabic to teach individuals how to eat better and live healthier. Then, collaboration will be undertaken with individuals in Saudi Arabia to ensure the program fits their needs. Afterward, the program will be tested with a small group of individuals to evaluate its effectiveness and acceptability. Approximately 20 individuals will be invited to join the program at King Abdullah Medical City. They will participate in ten online sessions, where they will learn about healthy eating and lifestyle improvements. Additionally, they will regularly weigh themselves. Data will be collected before and after the program to assess its impact on weight loss and overall well-being. By the end of the project, the investigators hope to have developed an effective program that assists Saudi individuals in losing weight and maintaining good health. ## Eligibility - **Minimum age:** 18 Years - **Maximum age:** 75 Years - **Sex:** ALL - **Healthy Volunteers:** Yes ``` Inclusion Criteria: * Adults within the age range of 18 to 75 years old * Individuals with a BMI greater than 25 kg/m² * Proficient in the Arabic language * Not currently pregnant or breastfeeding * Not using glucagon-like peptide -1 (GLP-1) or any weight loss medications * Have not undergone bariatric surgery * Possess Wi-Fi connectivity at their residence * Own a smartphone * Willing to provide consent for participation in 10 educational sessions spanning three months. Exclusion Criteria: * Individuals not meeting the inclusion criteria. ``` ## Arms - **A single-group, pre-post design to evaluate a three-month weight loss intervention in adult.** (EXPERIMENTAL) — Ten 40-minute education sessions appropriate to Saudi people will be developed and will cover essential topics for enhancing diet, lifestyle, and health. Each session comprises four modules, including activities and homework reviewed by a dietitian. Based on the EMPOWER weight loss program developed by the Nakamura lab for the US population, adjustments will be made to align with Saudi preferences, including food choices and cooking methods. Participants will access these materials online. ## Interventions - **Education sessions** (BEHAVIORAL) — Ten 40-minute education sessions appropriate to Saudi people will be developed and will cover essential topics for enhancing diet, lifestyle, and health. Each session comprises four modules, including activities and homework reviewed by a dietitian. Based on the EMPOWER weight loss program developed by the Nakamura lab for the US population, adjustments will be made to align with Saudi preferences, including food choices and cooking methods. Participants will access these materials online. ## Primary Outcomes - **Program feasibility and acceptability** _(time frame: 3 months)_ — Participants' views on the program's feasibility and acceptability will be gauged through structured surveys or interviews at the intervention's end. We'll employ two surveys: Feasibility Survey: this survey developed based on a previous study, examines various aspects like personal gain, program content, and engagement. Participants rate questions on a 1-5 scale and provide open-ended feedback. Feedback Survey: Participants will rate enjoyment, likelihood of recommendation, perceived benefits, and willingness to pay for services on a 1-5 scale. Open-ended questions will capture additional feedback. ## Secondary Outcomes - **Weight Loss** _(time frame: 3 months)_ ## Locations (1) - King Abdullah Medical City (KAMC), Mecca, Saudi Arabia ## Recent Field Changes (last 30 days) - `status.overallStatus` — added _(2026-05-12)_ - `status.primaryCompletionDate` — added _(2026-05-12)_ - `status.completionDate` — added _(2026-05-12)_ - `status.lastUpdatePostDate` — added _(2026-05-12)_ - `design.phases` — added _(2026-05-12)_ - `design.enrollmentCount` — added _(2026-05-12)_ - `eligibility.criteria` — added _(2026-05-12)_ - `eligibility.minAge` — added _(2026-05-12)_ - `eligibility.maxAge` — added _(2026-05-12)_ - `eligibility.sex` — added _(2026-05-12)_ - `outcomes.primary` — added _(2026-05-12)_ - `outcomes.secondary` — added _(2026-05-12)_ - `armsInterventions.arms` — added _(2026-05-12)_ - `armsInterventions.interventions` — added _(2026-05-12)_ - `sponsor.lead` — added _(2026-05-12)_ - `sponsor.collaborators` — added _(2026-05-12)_ - `results.hasResults` — added _(2026-05-12)_ - `locations.king abdullah medical city (kamc)|mecca||saudi arabia` — added _(2026-05-12)_ --- *Canonical: https://parkinsonspathways.com/agent/trials/NCT06415695.md* *Source data (authoritative): https://clinicaltrials.gov/study/NCT06415695* *This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*